Navellier & Associates Inc Charles River Laboratories International, Inc. Transaction History

Navellier & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $2.27 Million - $3.36 Million	-11,124 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$255.51 - $362.11 $469,627 - $665,558	-1,838 Reduced 14.18%	11,124 $3.16 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $1,054 - $1,346	-3 Reduced 0.02%	12,962 $4.88 Million
Q3 2021 Oct 28, 2021	BUY	$372.64 - $458.3 $142,348 - $175,070	382 Added 3.04%	12,965 $5.35 Million
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $3.7 Million - $4.68 Million	12,583 New	12,583 $4.66 Million

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.